These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 84854)

  • 21. The main antigenic determinant detected by neutralizing monoclonal antibodies on the intact foot-and-mouth disease virus particle is absent from isolated VPI.
    Meloen RH; Briaire J; Woortmeyer RJ; van Zaane D
    J Gen Virol; 1983 May; 64(Pt 5):1193-8. PubMed ID: 6188800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Location and characterization of the antigenic portion of the FMDV immunizing protein.
    Strohmaier K; Franze R; Adam KH
    J Gen Virol; 1982 Apr; 59(Pt 2):295-306. PubMed ID: 6176678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of trypsin and chymotrypsin on polypeptides of human rotavirus KUN strain.
    Sato T; Kitaoka S; Suzuki H; Konno T; Ishida N
    Med Microbiol Immunol; 1987; 176(2):65-73. PubMed ID: 3033457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Foot-and-mouth disease virus: immunogenicity and structure of fragments derived from capsid protein VP and of virus containing cleaved VP.
    Bachrach HL; Morgan DO; McKercher PD; Moore DM; Robertson BH
    Vet Microbiol; 1982 May; 7(2):85-96. PubMed ID: 6287701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antigenic comparison of the polypeptides of foot-and-mouth disease virus serotypes and other picornaviruses.
    Grubman MJ; Zellner M; Wagner J
    Virology; 1987 May; 158(1):133-40. PubMed ID: 2437694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protease digestion of hepatitis A virus: disparate effects on capsid proteins, antigenicity, and infectivity.
    Lemon SM; Amphlett E; Sangar D
    J Virol; 1991 Oct; 65(10):5636-40. PubMed ID: 1654460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neutralizing epitopes of type O foot-and-mouth disease virus. II. Mapping three conformational sites with synthetic peptide reagents.
    Parry NR; Barnett PV; Ouldridge EJ; Rowlands DJ; Brown F
    J Gen Virol; 1989 Jun; 70 ( Pt 6)():1493-503. PubMed ID: 2471812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody response against foot and mouth disease virus (FMDV). Part II: Responses measured in fractionated sera of infected steers with complete virus, trypsin treated virus, 12 S virus subunits, VIA and heterologous virus.
    Meloen RH
    Zentralbl Veterinarmed B; 1979 Jul; 26(5):358-65. PubMed ID: 93833
    [No Abstract]   [Full Text] [Related]  

  • 29. [Antigenic structure of the foot-and-mouth disease virus. III. Immunogenic properties of synthetic peptides of the sequence of the immunodominant region of VP1 proteins of the O1K and A22 strains of foot-and-mouth virus].
    Surovoĭ AIu; Gel'fanov VM; Vol'pina OM; Ivanov VT; Chepurkin AV; Chepurkin AV; Ivaniushchenkov VM; Driagalin NN; Burdov AN
    Bioorg Khim; 1989 Sep; 15(9):1185-92. PubMed ID: 2480134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antigenic specificity of porcine T cell response against foot-and-mouth disease virus structural proteins: identification of T helper epitopes in VP1.
    Rodríguez A; Sáiz JC; Novella IS; Andreu D; Sobrino F
    Virology; 1994 Nov; 205(1):24-33. PubMed ID: 7526534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The influence of the host cell, ionic strength and chymotrypsin on foot-and-mouth disease virus electrophoretic mobility.
    Vande Woude GF; Trautman R; Bachrach HL
    Arch Gesamte Virusforsch; 1967; 20(1):71-80. PubMed ID: 4299773
    [No Abstract]   [Full Text] [Related]  

  • 32. Demonstration of neutralizing and non-neutralizing epitopes on the trypsin-sensitive site of foot-and-mouth disease virus.
    Ouldridge EJ; Barnett PV; Parry NR; Syred A; Head M; Rweyemamu MM
    J Gen Virol; 1984 Jan; 65 ( Pt 1)():203-7. PubMed ID: 6198448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antigenicity and immunogenicity of synthetic peptides of foot-and-mouth disease virus.
    Meloen RH; Puyk WC; Meijer DJ; Lankhof H; Posthumus WP; Schaaper WM
    J Gen Virol; 1987 Feb; 68 ( Pt 2)():305-14. PubMed ID: 2434606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biochemical aspects of variation in foot-and-mouth disease virus.
    Robson KJ; Doel TR; Gorman BM; Brown F
    J Gen Virol; 1980 Jan; 46(1):179-93. PubMed ID: 6243341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selection of antigenic variants of foot-and-mouth disease virus in the absence of antibodies, as revealed by an in situ assay.
    Diez J; Mateu MG; Domingo E
    J Gen Virol; 1989 Dec; 70 ( Pt 12)():3281-9. PubMed ID: 2481712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antigenic structure of the foot-and-mouth disease virus. II. Synthesis of protective peptides from the major immunogenic region of VP1 protein of foot-and-mouth disease virus type A22].
    Vol'pina OM; Surovoĭ AIu; Ul'iashin VV; Ivanov VT; Chepurkin AV
    Bioorg Khim; 1988 Oct; 14(10):1363-71. PubMed ID: 2852938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A study of antigenic variants of foot-and-mouth disease virus by polyacrylamide gel electrophoresis of their structural polypeptides.
    Knowles NJ; Hedger RS
    Vet Microbiol; 1985 Jun; 10(4):347-57. PubMed ID: 2412337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Routine physico-chemical testing of concentrated virulent and inactivated foot-and-mouth disease virus antigens].
    Adamowicz P; Guerche J; Galampoix J; Prunet P
    Dev Biol Stand; 1976; 35():301-10. PubMed ID: 198300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surface structure of foot-and-mouth disease virus.
    Wild TF; Burroughs JN; Brown F
    J Gen Virol; 1969 Apr; 4(3):313-20. PubMed ID: 4306712
    [No Abstract]   [Full Text] [Related]  

  • 40. Neutralization of foot-and-mouth disease virus can be mediated through any of at least three separate antigenic sites.
    Xie QC; McCahon D; Crowther JR; Belsham GJ; McCullough KC
    J Gen Virol; 1987 Jun; 68 ( Pt 6)():1637-47. PubMed ID: 2438378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.